{
    "organizations": [],
    "uuid": "5b2e78e4a6e7e8431d054d46816d7e51cb9be402",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-adverum-biotechnologies-prices-60/brief-adverum-biotechnologies-prices-60-mln-public-offering-of-stock-idUSASB0C4S9",
    "ord_in_thread": 0,
    "title": "BRIEF-Adverum Biotechnologies Prices $60 Mln Public Offering Of Stock",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 8 (Reuters) - Adverum Biotechnologies Inc:\n* ADVERUM BIOTECHNOLOGIES ANNOUNCES PRICING OF $60 MILLION PUBLIC OFFERING OF COMMON STOCK\n* SAYS PUBLIC OFFERING OF 8.89 MILLION COMMON SHARES PRICED AT $6.75PER SHARE\n* PRICING OF AN UNDERWRITTEN PUBLIC OFFERING OF 8.8 MILLION SHARES OF ITS COMMON STOCK AT A PRICE TO PUBLIC OF $6.75 PER SHARE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-08T21:21:00.000+02:00",
    "crawled": "2018-02-09T16:33:29.018+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "adverum",
        "biotechnology",
        "inc",
        "adverum",
        "biotechnology",
        "announces",
        "pricing",
        "million",
        "public",
        "offering",
        "common",
        "stock",
        "say",
        "public",
        "offering",
        "million",
        "common",
        "share",
        "priced",
        "share",
        "pricing",
        "underwritten",
        "public",
        "offering",
        "million",
        "share",
        "common",
        "stock",
        "price",
        "public",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}